ArticleVeterinary research communications2026
Evaluation of a commercial multispecies rapid test for anti-Leishmania infantum antibodies in unconventional animal species.
Article in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Point-of-care serology in feline leishmaniosis: A diagnostic gap requiring species-specific solutions.Current research in parasitology & vector-borne diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Leishmania infantum is a vector-borne protozoan causing zoonotic visceral leishmaniasis in the Mediterranean basin, where dogs are the primary reservoir. However, infection in various domestic and wild mammals raises questions about their epidemiological roles. Reliable diagnosis in non-canine species remains challenging, as most serological assays are developed for dogs and cats. This study evaluated a commercially available multispecies rapid immunochromatographic test (Uranotest® Leishmania feline) for detecting anti-Leishmania antibodies in a diverse panel of domestic and non-domestic animals. A total of 186 serum samples from different species were analyzed, previously classified as seropositive (n = 65) or seronegative (n = 121) using an in-house ELISA as reference. Immunochromatographic rapid test performance was compared to ELISA results using Cohen’s kappa to assess agreement. Overall agreement reached 82.3% (κ = 0.56), indicating moderate concordance. This immunochromatographic test correctly identified all positive and negative canine and feline samples and showed perfect agreement in other carnivores such as mink and wolves. In contrast, all herbivorous species, including alpaca, horses, goats, llama, sheep, bison, and dromedaries, produced negative results by the rapid test despite ELISA seropositivity, suggesting limited affinity of the conjugate for herbivore immunoglobulins. These findings indicate that, while the assayed rapid test is suitable for detecting anti-Leishmania antibodies in non-herbivorous species, it is unreliable for herbivores. The study highlights the importance of species-specific validation of serological assays and suggests that rapid tests using protein A conjugates may have restricted cross-species utility, reinforcing the need for adapted diagnostic tools in multispecies and wildlife contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.